NECC had to be punished earlier

In 2003 the FDA planned to shut down the New England Compounding Center (NECC) which last year caused the meningitis outbreak in certain states of America. The Massachusetts pharmacy produced tainted Methylprednisolone Acetate injections. Over 400 individuals who used the tainted steroid injections were sickened with fungal meningitis. This illness turned out to be tragic for 39 persons.
According to a recent report published by the House of Energy and Commerce Committee, the meningitis outbreak could have been prevented. The report revealed many cases connected with the Massachusetts pharmacy that should have been shut down by the FDA earlier.
The FDA stated in 2003 that the Massachusetts pharmacy should not have manufactured preparations till improving of the situation. But finally the FDA didn’t ban manufacture of medications at the NECC. Since the NECC was considered to be a pharmacy, it should have been ruled by Massachusetts officials. So, the FDA let Massachusetts colleagues to resolve the problem. As for Massachusetts officials, they didn’t ban manufacture of preparations at once. The NECC continued to manufacture drugs. Only Barry Cadden, the owner of the NECC, got reprimand.
Furthermore, the NECC was guilty of certain illicit operations. The company acted inappropriately under its license. Being a pharmacy, the NECC acted as a manufacturer and sent thousands doses of medicines to hospitals and individual patients.
In 2002 some individuals suffered from unusual negative results after they had used bethamethasone injections produced by the Massachusetts pharmacy.
Later some persons who administered methylprednisolone acetate injections produced by the NECC were contaminated with bacterial meningitis. Since these persons received complete recovery because of treatment with antibiotics, the case was forgotten. The NECC was not punished for the tainted drugs.
These and even some other cases manifest that the Massachusetts company should have punished earlier. The company should have been closed for its illegal and inappropriate actions. But the Compounding Center was never sentenced to any severe penalties. As a result, the pharmacy continued to manufacture drugs that were dangerous for consumers’ health. Ultimately, the meningitis outbreak caused by tainted injections of the Massachusetts pharmacy spread to several states and sickened many persons. If the company had been closed earlier, the contamination with deadly fungal meningitis would not have taken place.